...its immuno-oncology quiver. Since November 2018, the Japanese pharma has acquired CAR T platform developer Xyphos Biosciences Inc....
...gilteritinib for acute myelogenous leukemia and antibody-drug conjugate Padcev enfortumab vedotin-ejfv for bladder cancer (see “Xyphos...

...front for Xyphos Biosciences Inc., and the biotech’s shareholders are eligible for $545 million in milestones. With Xyphos’...
...top, we climbed every rung a deal must go up.” James Knighton, Xyphos According to Xyphos...
...also be used to treat HIV (see “Gladstone, Xyphos Target CARs to Latent HIV” ). Xyphos’...

...too costly, he said. In a Cell paper published on Thursday, the team described deploying Xyphos’...
...convertible CAR platform to improve the safety of anti-HIV CAR Ts and prevent viral escape. Xyphos...
...T target requires altering only the MicAbody antigen-binding end (see “Avidly Specific” ). Greene and Xyphos...

...company RefleXion Medical Inc. (Hayward, Calif.) hired Thorsten Melcher as CBO. He was CBO at Xyphos Biosciences Inc....

...the Parker Institute for Cancer Immunotherapy to develop CAR Ts using Xyphos' convertible CAR platform. Xyphos...
...research will focus primarily on treating solid tumors, which traditional CAR Ts have difficulty entering. Xyphos...
...They will evaluate the partnered therapies against known, undisclosed cancer cell surface targets, Knighton said. Xyphos...

...the Parker Institute for Cancer Immunotherapy to develop CAR Ts using Xyphos' convertible CAR platform. Xyphos...
...research will focus primarily on treating solid tumors, which traditional CAR Ts have difficulty entering. Xyphos...
...They will evaluate the partnered therapies against known, undisclosed cancer cell surface targets, Knighton said. Xyphos...

...Pharmaceuticals Inc. subsidiary of Sumitomo Dainippon Pharma Co. Ltd. (Tokyo:4506). Modular CAR T cell company Xyphos...

...Corp (South San Francisco, Calif.) said it will split into two separate entities. One company, Xyphos...
...using its Avidocin technology. Both companies will be located initially in South San Francisco, Calif. Xyphos'...
...AvidBiotics Corp., South San Francisco, Calif. Business: Cancer, infectious disease Elizabeth S. Eaton AvidBiotics Corp. Pylum Biosciences Inc. Xyphos...